Abstract
Dr. Xiufeng Ye and Dr. Guangfu Chen are both co-corresponding authors.
Accordingly, please make the following two corrections to the paper:
1) Add * to the author Xiufeng Ye.
2) *Address correspondence to Dr. Chen guangfu, szchengf@email.szu.edu.cn or Dr. Xiufeng Ye, szrosexiu@ 126.com, Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035, China.
Current Neurovascular Research
Title:Erratum: Erythropoietin Gene Polymorphism rs551238 is Associated with a Reduced Susceptibility to Brain Injury in Preterm Infants
Volume: 17 Issue: 3
Author(s): Xiufeng Ye*Guangfu Chen*
Affiliation:
- Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035,China
- Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035,China
Abstract: Dr. Xiufeng Ye and Dr. Guangfu Chen are both co-corresponding authors.
Accordingly, please make the following two corrections to the paper:
1) Add * to the author Xiufeng Ye.
2) *Address correspondence to Dr. Chen guangfu, szchengf@email.szu.edu.cn or Dr. Xiufeng Ye, szrosexiu@ 126.com, Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035, China.
Export Options
About this article
Cite this article as:
Ye Xiufeng *, Chen Guangfu *, Erratum: Erythropoietin Gene Polymorphism rs551238 is Associated with a Reduced Susceptibility to Brain Injury in Preterm Infants, Current Neurovascular Research 2020; 17 (3) . https://dx.doi.org/10.2174/156720261703200929114209
DOI https://dx.doi.org/10.2174/156720261703200929114209 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development and Tailoring of Hybrid Lipid Nanocarriers
Current Pharmaceutical Design Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
Current Pharmaceutical Design Therapeutic Window, a Critical Developmental Stage for Stem Cell Therapies
Current Stem Cell Research & Therapy Artificial O2 Carriers: Status in 2005
Current Pharmaceutical Design Ex Vivo Gene Transfer for Improvement of Transplanted Pancreatic Islet Viability and Function
Current Pharmaceutical Design Cannabinoids and Neuropathic Pain
Mini-Reviews in Medicinal Chemistry Targeting Sphingosine-1-Phosphate Receptors in Cancer
Anti-Cancer Agents in Medicinal Chemistry Metabolic Syndrome Targets
Current Drug Targets - CNS & Neurological Disorders Iron Oxide Nanoparticles: An Insight into their Biomedical Applications
Current Medicinal Chemistry Erythropoietin Treatment in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Drug Delivery Longitudinal Functional MRI of Motor and Cognitive Recovery Following Stroke: A Review
Current Medical Imaging The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets Nanotechnological Strategies for the Treatment of Neglected Diseases
Current Pharmaceutical Design Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy A Review of Studies on Targeting Interleukin 4 Receptor for Central Nervous System Malignancy
Current Molecular Medicine Glucocorticoid Analogues: Potential Therapeutic Alternatives for Treating Inflammatory Muscle Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Exosomes Harnessed as Nanocarriers for Cancer Therapy - Current Status and Potential for Future Clinical Applications
Current Molecular Medicine Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review
Drug Delivery Letters Amyloid Beta Peptide, 4-Hydroxynonenal and Apoptosis
Current Alzheimer Research Inflammatory Process in Alzheimer’s and Parkinson's Diseases: Central Role of Cytokines
Current Pharmaceutical Design